
Talphera, a specialty pharmaceutical firm in Redwood City, develops and commercializes therapies, including innovative pain management systems.
Talphera, based in Redwood City, is a specialty pharmaceutical company dedicated to developing and commercializing innovative therapies for medically supervised settings. Its core products include NanoTab, an oral transmucosal tablet, and the Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system designed for acute postoperative pain management. Talphera aims to enhance patient outcomes by providing high-quality tools that offer improved cost and convenience for healthcare providers.
Talphera has made significant strides in the pharmaceutical industry with its cutting-edge pain management systems. The Sufentanil NanoTab PCA system, in particular, represents a notable advancement in patient-controlled analgesia, offering a combination of drug and device for effective pain relief. By focusing on the needs of both patients and medical teams, Talphera has positioned itself as a leader in optimizing care outcomes in hospital settings.
Pacira BioSciences
pacira.com

Toralgen
toralgen.com

Talima Therapeutics
talima.com

Trigemina

Solace Pharmaceuticals

Thermaquil
thermaquil.com

Tremeau Pharmaceuticals

Phoenix PharmaLabs

Sarentis Therapeutics

NeuroTherapeutics Pharma

Isosceles Pharmaceuticals

Concentric Analgesics

Scilex Holding Company
scilexholding.com

Cytogel Pharma
cytogelpharma.com

Allay Therapeutics
allaytx.com
Companies similar to Talphera include Pacira BioSciences, Toralgen, Talima Therapeutics and Trigemina.
Talphera was founded in 2005.
Talphera's headquarters is located in Redwood City, CA, US.
Talphera's most recent funding round was for $6M (USD) in January 2024.
As of Jan 18, 2024, Talphera has raised a total of $191.7M (USD).
Talphera has 37 employees as of Feb 5, 2024.